# Study on Incidence of Diabetic Ketoacidosis Among Participants With Type 2 Diabetes Mellitus Treated With Sodium-glucose Co-transporter 2 (SGLT2) Inhibitors or Other Antihyperglycemic Agents

> **NCT02636192** · — · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 200000 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** No Intervention

## Key facts

- **NCT ID:** NCT02636192
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07-31
- **Primary completion:** 2017-04-07
- **Final completion:** 2017-04-07
- **Target enrollment:** 200000 (ACTUAL)
- **Last updated:** 2017-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02636192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02636192, "Study on Incidence of Diabetic Ketoacidosis Among Participants With Type 2 Diabetes Mellitus Treated With Sodium-glucose Co-transporter 2 (SGLT2) Inhibitors or Other Antihyperglycemic Agents". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02636192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*